- Home
- LMNR vs DCTH Comparison
LMNR vs DCTH Comparison
Compare LMNR & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMNR
- DCTH
- Stock Information
- Founded
- LMNR 1893
- DCTH 1988
- Country
- LMNR United States
- DCTH United States
- Employees
- LMNR N/A
- DCTH N/A
- Industry
- LMNR Farming/Seeds/Milling
- DCTH Medical/Dental Instruments
- Sector
- LMNR Consumer Staples
- DCTH Health Care
- Exchange
- LMNR Nasdaq
- DCTH Nasdaq
- Market Cap
- LMNR 440.5M
- DCTH 518.0M
- IPO Year
- LMNR N/A
- DCTH N/A
- Fundamental
- Price
- LMNR $17.72
- DCTH $12.73
- Analyst Decision
- LMNR Hold
- DCTH Strong Buy
- Analyst Count
- LMNR 1
- DCTH 4
- Target Price
- LMNR $23.00
- DCTH $22.75
- AVG Volume (30 Days)
- LMNR 77.0K
- DCTH 470.4K
- Earning Date
- LMNR 03-12-2025
- DCTH 03-06-2025
- Dividend Yield
- LMNR 1.69%
- DCTH N/A
- EPS Growth
- LMNR N/A
- DCTH N/A
- EPS
- LMNR 0.43
- DCTH N/A
- Revenue
- LMNR $186,077,000.00
- DCTH $37,205,000.00
- Revenue This Year
- LMNR $6.42
- DCTH $112.81
- Revenue Next Year
- LMNR $5.90
- DCTH $61.78
- P/E Ratio
- LMNR $41.11
- DCTH N/A
- Revenue Growth
- LMNR 2.39
- DCTH 1701.69
- 52 Week Low
- LMNR $17.12
- DCTH $4.26
- 52 Week High
- LMNR $29.22
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- LMNR 28.39
- DCTH 41.24
- Support Level
- LMNR $17.12
- DCTH $11.11
- Resistance Level
- LMNR $18.40
- DCTH $14.61
- Average True Range (ATR)
- LMNR 0.96
- DCTH 0.76
- MACD
- LMNR -0.02
- DCTH 0.04
- Stochastic Oscillator
- LMNR 12.85
- DCTH 36.27
About LMNR Limoneira Co
Limoneira Co is an agribusiness company. The company's operating segments include Fresh Lemons; Lemon Packing; Avocados and Other Agribusiness. It generates maximum revenue from the Fresh Lemons segment.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.